The P/E ratio divided by the EPS growth rate it is set against.
—
PEG Ratio
Our price is for one ADS, which represents 2 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
—
Growth Rate Source
Good Data Quality5-Year EPS CAGR
Current Price
$26.42
TTM EPS
$0.72
latest full year (FY2025)
P/E Ratio
—
Growth Rate
7.0%
5-Year EPS CAGR
Sector
Healthcare
Medical - Devices
Calculated
10/3/2026
1:59:01 PM
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
PEG Ratio Unavailable
Our price is for one ADS, which represents 2 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.
Peer Comparison
Sample Size
3 peers
Industry Median PEG
2.25
25th Percentile
0.70
75th Percentile
7.27
Symbol
Company
PEG
P/E
Growth
vs SNN
CNMD
CONMED Corp
0.70
25.0
35.7%
—
STE
STERIS plc
2.25
25.5
11.3%
—
ITGR
Integer Holdings Corp
7.27
34.4
4.7%
—
How to Read a PEG Ratio
PEG < 1.0. The P/E is a smaller number than the percentage growth rate it is divided by — the price pays less than one turn of multiple per point of growth.
PEG 1.0–2.0. The P/E is one to two times the growth rate. PEG 1.0 is the reference point where the two are equal.
PEG > 2.0. The P/E is more than twice the growth rate. Whether that is worth paying depends on how durable the growth is, which the ratio does not measure.
Limitations: PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.
